Sign in
4

Changes in Ownership

Aptevo Therapeutics Inc. Filed Acc 0001019056-20-000441

Options or other derivatives

  • CEO and President acquired 21,438 shares (grant or award)
  • CEO and President returned 49,348 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
White Marvin L CEO and President 2020-07-27 Returned to the company · Stock Option (right to buy) −2,545 0 D
White Marvin L CEO and President 2020-07-27 Returned to the company · Stock Option (right to buy) −14,319 0 D
White Marvin L CEO and President 2020-07-27 Returned to the company · Stock Option (right to buy) −5,414 0 D
White Marvin L CEO and President 2020-07-27 Returned to the company · Stock Option (right to buy) −5,414 0 D
White Marvin L CEO and President 2020-07-27 Returned to the company · Stock Option (right to buy) −10,828 0 D
White Marvin L CEO and President 2020-07-27 Returned to the company · Stock Option (right to buy) −10,828 0 D
White Marvin L CEO and President 2020-07-27 Grant or award · Stock Option (right to buy) +16,625 16,625 D
White Marvin L CEO and President 2020-07-27 Grant or award · Stock Option (right to buy) +4,813 4,813 D
Loading xslF345X03/white.xml…